Chemed Corporation

NYSE:CHE Voorraadrapport

Marktkapitalisatie: US$8.5b

Chemed Inkomsten in het verleden

Verleden criteriumcontroles 6/6

Chemed is de winst gegroeid met een gemiddeld jaarlijks percentage van 1.8%, terwijl de Healthcare industrie de winst jaarlijks groeide met 5.4%. De inkomsten zijn gegroeid met een gemiddelde snelheid van 3.5% per jaar. Het rendement op eigen vermogen van Chemed is 24.4%, en het heeft een nettomarge van 12.7%.

Belangrijke informatie

1.8%

Groei van de winst

3.4%

Groei van de winst per aandeel

Healthcare Groei van de industrie8.5%
Inkomstengroei3.5%
Rendement op eigen vermogen24.4%
Nettomarge12.7%
Laatste winstupdate30 Sep 2024

Recente prestatie-updates uit het verleden

Recent updates

The Chemed Corporation (NYSE:CHE) Third-Quarter Results Are Out And Analysts Have Published New Forecasts

Nov 01
The Chemed Corporation (NYSE:CHE) Third-Quarter Results Are Out And Analysts Have Published New Forecasts

Chemed Corporation's (NYSE:CHE) Business Is Yet to Catch Up With Its Share Price

Oct 29
Chemed Corporation's (NYSE:CHE) Business Is Yet to Catch Up With Its Share Price

Capital Investments At Chemed (NYSE:CHE) Point To A Promising Future

Aug 26
Capital Investments At Chemed (NYSE:CHE) Point To A Promising Future

Chemed Remains A Buy On Long-Term Economics

Aug 16

Chemed Corporation's (NYSE:CHE) Shares May Have Run Too Fast Too Soon

Jul 19
Chemed Corporation's (NYSE:CHE) Shares May Have Run Too Fast Too Soon

Chemed: Growth Does Not Justify The Current Stock Price

May 20

Here's Why Chemed Corporation's (NYSE:CHE) CEO Compensation Is The Least Of Shareholders' Concerns

May 14
Here's Why Chemed Corporation's (NYSE:CHE) CEO Compensation Is The Least Of Shareholders' Concerns

Is Chemed Corporation (NYSE:CHE) Trading At A 50% Discount?

Apr 26
Is Chemed Corporation (NYSE:CHE) Trading At A 50% Discount?

Chemed Corporation (NYSE:CHE) Full-Year Results: Here's What Analysts Are Forecasting For This Year

Mar 01
Chemed Corporation (NYSE:CHE) Full-Year Results: Here's What Analysts Are Forecasting For This Year

The Price Is Right For Chemed Corporation (NYSE:CHE)

Dec 30
The Price Is Right For Chemed Corporation (NYSE:CHE)

Chemed: Continues To Compound Shareholder Value At Double-Digit Returns

Nov 30

Chemed (NYSE:CHE) Is Aiming To Keep Up Its Impressive Returns

Oct 26
Chemed (NYSE:CHE) Is Aiming To Keep Up Its Impressive Returns

Chemed - Showcasing Why It's So Reliable

Aug 26

Chemed: Still Bullish On Economic Characteristics, But Risks Shouldn't Be Overlooked

Aug 13

Is Chemed Corporation (NYSE:CHE) Worth US$521 Based On Its Intrinsic Value?

Aug 01
Is Chemed Corporation (NYSE:CHE) Worth US$521 Based On Its Intrinsic Value?

Capital Investments At Chemed (NYSE:CHE) Point To A Promising Future

Jul 14
Capital Investments At Chemed (NYSE:CHE) Point To A Promising Future

Chemed (NYSE:CHE) Has A Rock Solid Balance Sheet

Jun 07
Chemed (NYSE:CHE) Has A Rock Solid Balance Sheet

Chemed (NYSE:CHE) Is Aiming To Keep Up Its Impressive Returns

Apr 09
Chemed (NYSE:CHE) Is Aiming To Keep Up Its Impressive Returns

Chemed Q4 2022 Earnings Preview

Feb 22

Chemed Corporation: Long-Term Tailwinds, But Remains A Hold

Feb 14

Is Chemed (NYSE:CHE) Using Too Much Debt?

Jan 05
Is Chemed (NYSE:CHE) Using Too Much Debt?

Here's What Chemed's (NYSE:CHE) Strong Returns On Capital Mean

Dec 17
Here's What Chemed's (NYSE:CHE) Strong Returns On Capital Mean

Chemed declares $0.38 dividend

Nov 04

Chemed Q3 2022 Earnings Preview

Oct 28

Does Chemed (NYSE:CHE) Have A Healthy Balance Sheet?

Oct 01
Does Chemed (NYSE:CHE) Have A Healthy Balance Sheet?

Opbrengsten en kosten

Hoe Chemed geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.

Inkomsten en omzetgeschiedenis

NYSE:CHE Opbrengsten, kosten en inkomsten (USD Millions )
DatumInkomstenInkomstenG+A UitgavenR&D-uitgaven
30 Sep 242,3773024150
30 Jun 242,3363014130
31 Mar 242,2932834110
31 Dec 232,2642733950
30 Sep 232,2252453920
30 Jun 232,1872263760
31 Mar 232,1652403690
31 Dec 222,1352503590
30 Sep 222,1292623540
30 Jun 222,1412773590
31 Mar 222,1422673650
31 Dec 212,1392693670
30 Sep 212,1323083610
30 Jun 212,1213033610
31 Mar 212,0913293510
31 Dec 202,0803193300
30 Sep 202,0692713220
30 Jun 202,0212633110
31 Mar 201,9922312980
31 Dec 191,9392203060
30 Sep 191,8742092890
30 Jun 191,8372012790
31 Mar 191,8062052760
31 Dec 181,7832062710
30 Sep 181,7532062760
30 Jun 181,7271902750
31 Mar 181,7001132710
31 Dec 171,667982710
30 Sep 171,642762610
30 Jun 171,617672540
31 Mar 171,5921142490
31 Dec 161,5771092380
30 Sep 161,5721062400
30 Jun 161,5661082340
31 Mar 161,5571112330
31 Dec 151,5431102330
30 Sep 151,5241102290
30 Jun 151,4961062290
31 Mar 151,4751032240
31 Dec 141,456992200
30 Sep 141,425922160
30 Jun 141,408852110
31 Mar 141,405762100
31 Dec 131,413772130

Kwaliteitswinsten: CHE heeft hoge kwaliteitsinkomsten.

Groeiende winstmarge: De huidige netto winstmarges (12.7%) CHE } zijn hoger dan vorig jaar (11%).

Analyse vrije kasstroom versus winst

Analyse van de winstgroei in het verleden

Winsttrend: De winst van CHE is de afgelopen 5 jaar met 1.8% per jaar gegroeid.

Versnelling van de groei: De winstgroei van CHE over het afgelopen jaar ( 23.4% ) overtreft het 5-jarig gemiddelde ( 1.8% per jaar).

Winst versus industrie: De winstgroei CHE over het afgelopen jaar ( 23.4% ) overtrof de Healthcare -sector 10.3%.

Rendement op eigen vermogen

Hoge ROE: Het Rendement op eigen vermogen ( 24.4% ) van CHE wordt als hoog beschouwd.

Rendement op activa

Rendement op geïnvesteerd vermogen

Ontdek sterk presterende bedrijven uit het verleden

7D

1Y

7D

1Y

7D

1Y